1.
Loss of SUFU Function in Familial Multiple Meningioma
by Aavikko, Mervi
American journal of human genetics, 2012, Vol.91 (3), p.520-526
2.
Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]
by Evans, D Gareth R
Genetics in medicine, 2009, Vol.11 (9), p.599-610
3.
Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligat...
by Evans, D Gareth R
Journal of medical genetics, 2007, Vol.44 (7), p.424-428
4.
Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis
by Burkitt Wright, Emma MM
Journal of medical genetics, 2013, Vol.50 (9), p.606-613
5.
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at...
by Smith, Miriam J
Journal of medical genetics, 2011, Vol.48 (4), p.261-265
6.
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis
by Smith, Miriam J
Neurogenetics, 2012, Vol.13 (2), p.141-145
7.
Predictors of the Risk of Mortality in Neurofibromatosis 2
by Baser, Michael E
American journal of human genetics, 2002, Vol.71 (4), p.715-723
8.
A Dominantly Inherited 5′ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
by Evans, D.Gareth R
American journal of human genetics, 2018, Vol.103 (2), p.213-220
9.
Genotype-Phenotype Correlations for Nervous System Tumors in Neurofibromatosis 2: A Population-Based Study
by Baser, Michael E
American journal of human genetics, 2004, Vol.75 (2), p.231-239
10.
Empirical development of improved diagnostic criteria for neurofibromatosis 2
by Baser, Michael E.
Genetics in medicine, 2011, Vol.13 (6), p.576-581
11.
Germline SDHD mutation in familial phaeochromocytoma
by Astuti, Dewi
The Lancet (British edition), 2001, Vol.357 (9263), p.1181-1182
12.
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history
by Lalloo, Fiona
The Lancet (British edition), 2003, Vol.361 (9363), p.1101-1102
13.
A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer
by Froggatt, Nicola J
Journal of medical genetics, 1999, Vol.36 (2), p.97-102
14.
Neurofibromatosis type 2
by Evans, D Gareth R
Journal of Medical Genetics, 2000, Vol.37 (12), p.897-904
15.
Are There Low-Penetrance TP53 Alleles? Evidence from Childhood Adrenocortical Tumors
by Varley, Jennifer M
American journal of human genetics, 1999, Vol.65 (4), p.995-1006
16.
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing
by Evans, D G R
Journal of medical genetics, 2009, Vol.46 (12), p.811-817
17.
The accuracy of diagnoses as reported in families with cancer: a retrospective study
by Douglas, Fiona S
Journal of medical genetics, 1999, Vol.36 (4), p.309-312
18.
Neurofibromatosis type 2 (NF2): diagnosis and management
by EVANS, GARETH
Peripheral Nerve Disorders, 2013, p.957-967
19.
SMARCB1 mutations are not a common cause of multiple meningiomas
by Hadfield, K D
Journal of medical genetics, 2010, Vol.47 (8), p.567-568
20.
Multiple meningiomas: differential involvement of the NF2 gene in children and adults
by Evans, D G R
Journal of medical genetics, 2005, Vol.42 (1), p.45-48
